# A Prospective Evaluation of Natriuretic Peptide Based Referral of CHF Patients in Primary Care

> **NCT02807857** · NA · COMPLETED · sponsor: **Novartis Pharmaceuticals** · enrollment: 1415 (actual)

## Conditions studied

- Chronic Heart Failure (CHF)

## Interventions

- **PROCEDURE:** Standard care

## Key facts

- **NCT ID:** NCT02807857
- **Lead sponsor:** Novartis Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-07-07
- **Primary completion:** 2018-03-23
- **Final completion:** 2018-03-23
- **Target enrollment:** 1415 (ACTUAL)
- **Last updated:** 2021-02-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02807857

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02807857, "A Prospective Evaluation of Natriuretic Peptide Based Referral of CHF Patients in Primary Care". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02807857. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*